LOS ANGELES, CA, Lifeforce, the first comprehensive, clinically integrated health optimization platform, today announced the close of its $12 million Series A funding round.
The round was co-led by M13 and Peterson Ventures. The oversubscribed round also includes participation by Ridgeline Ventures, Rosecliff Ventures, and Seaside Ventures. In a fragmented healthcare market, Lifeforce operates as the trusted partner for people seeking to take proactive control of their health by bringing together the biomarker data, clinical expertise, and validated interventions needed to optimize health and longevity.
Lifeforce empowers adults to take control of their health, by combining the data, tools, and expertise to think clearer, feel stronger, and ultimately, live longer. On a mission to improve quality of life for 5M people by 2030, Lifeforce simplifies and consolidates members' health ecosystems into the first clinically integrated health optimization platform. Through convenient at-home diagnostics, access to expert functional medicine physicians and certified health coaches, and data-driven highly personalized care plans, Lifeforce redefines the way we approach preventative healthcare and aging.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about